[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"human-papillomavirus-hpv-vaccines\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:human-papillomavirus-hpv-vaccines":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100318719","maximizing-hpv-vaccination-real-time-reminders-guidance-and-recommendations---part-4-feasibility-trial-100318719",false,"NCT03429413","Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial","Inclusion Criteria:\n\n* Must be parent of an adolescent aged 11-12 years old.\n* Providers working with age appropriate for study adolescents at the intervention clinics\n* Adolescents\u002FParents\u002FProviders willing to consent to participation\n* Adolescents\u002FParents that can read and speak English\n\nExclusion Criteria:\n\n* Adolescents out of the age range for participation\n* Adolescents\u002FParents\u002FProviders unwilling to consent to participation\n* Adolescents\u002FParents that can NOT read and speak English",true,"ALL","18 Years","99 Years",{"count":20,"type":21},1296,"ESTIMATED","INTERVENTIONAL",[24],"NA","Human papillomavirus (HPV) vaccines have potential to prevent an average of 26,900 cancer cases each year in the United States, but vaccine coverage rates remain low. The study team has developed an electronic application (app), Protect Me 4, to help parents and providers assess and have more productive conversations about needed vaccines.\n\nThe specific aims of this study are to: (1) evaluate the feasibility of implementing Protect Me 4, and (2) estimate preliminary efficacy of Protect Me 4 to increase HPV vaccine initiation (receipt of first dose).",[27],"Human Papillomavirus (HPV) Vaccines",[29],"Health Information Technology (HIT)","NOT_YET_RECRUITING","2026-09-11",{"date":33,"type":34},"2026-09-14","ACTUAL",{"date":36,"type":21},"2027-09-15",{"date":38,"type":21},"2028-09-15",{"name":40,"class":41},"University of Florida","OTHER"]